Global Vasomotor Symptoms Treatment Market Size to Grow at a CAGR of 6.70% During the Forecast Period of 2023-2031

The ‘Global Vasomotor Symptoms Treatment Market Analysis, Size, Share, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global vasomotor symptoms treatment market, assessing the market on the basis of its segments like route of administration, type of therapy, distribution channel, and major regions.

The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Vasomotor Symptoms Treatment Market Share, Size, Price, Growth, Trends, Industry Report, Key Player, Major Segments and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

  • Historical Market Size (2022): USD 8.8 billion
  • Forecast CAGR (2023-2031): 6.70%
  • Forecast Market Size (2031): USD 15.7 billion

The global vasomotor symptoms treatment market growth is anticipated to be boosted by the rising prevalence of vasomotor symptoms, such as hot flashes and night sweats, among women during the menopausal transition. The number of women 50 years and older is growing every year, according to data from the United Nations. Thus, as the population grows, so will the variety of menopause symptoms, which will increase the market demand.

Get a Free Sample Report with Table of Contents@

Many public and commercial organisations are increasing their efforts in the creation of cutting-edge interventions and therapies, which will further accelerate market expansion for vasomotor symptoms treatment. The market is expanding as a result of numerous expansion tactics, including mergers and acquisitions by significant industry participants.

It is expected that North America would represent the largest revenue share of the global vasomotor symptoms treatment market. This is brought on by the widespread occurrence of post-menopausal symptoms, increased awareness of women’s health issues, and developed healthcare infrastructure. It is also anticipated that the strong presence of major international players in this region will accelerate the market expansion.

Vasomotor Symptoms Treatment Industry Definition and Major Segments

Vasomotor symptoms refer to the symptoms that take place during menopause as a result of blood vessel constrictions. Some of the typical vasomotor symptoms include night sweats, hot flashes, and variations in blood pressure. Vasomotor symptoms manifest during menopause due to the significant hormonal changes taking place that can influence the body’s temperature and blood pressure regulators. As a result of the large drop in oestrogen levels, patients become restless.

Read Full Report with Table of Contents@

Based on route of administration, the market is segmented into:

  • Oral
  • Parenteral
    • Subcutaneous
    • Intravenous
  • Topical

On the basis of type of therapy, the market is divided into:

  • Hormonal Therapies
    • Estrogen Replacement Therapies
    • Pregestational Therapies
  • Non-Hormonal Therapies
    • Clonidine
    • Serotonin Reuptake Inhibitors
    • Gabapentin
  • Others

Based on distribution channel, the market is classified into:

  • Hospital Based Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

On the basis of region, the market is divided into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Vasomotor Symptoms Treatment Market Trends

The key trends in the global vasomotor symptoms treatment market including rising public awareness of treatments and significant advancements in the pharmaceutical sector. Due to the availability of prominent drugs in the hospital pharmacy and the requirement for prescriptions to buy such drugs, hospital pharmacies held a significant market share. However, it is anticipated that over the forecast period, the segment for online pharmacies will grow the fastest, owing to the growing popularity of online pharmacies. Additionally, these platforms often provide a variety of discounts to customers.

The expansion of the global vasomotor symptoms treatment market is being fuelled by the growing spending in research and development activities by major players, which will help in the development of new treatment methods. Additional reasons that are contributing to the market’s expansion include an increase in the adoption of sedentary lifestyles, a rise in the number of mergers and acquisitions, and increased awareness of vasomotor symptoms.

Key Market Players

The major players in the global vasomotor symptoms treatment market report are:

  • Bayer AG
  • Fervent Pharmaceuticals, LLC
  • Astellas Pharma Inc.
  • Frazier Healthcare Partners
  • Mitsubishi Tanabe Pharma Corporation
  • Eli Lilly and Company
  • AbbVie Inc.
  • AMAG Pharmaceuticals Inc.
  • Emcure Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Read More Reports:

Human Resource Management Market:

Hydrogenated Nitrile Butadiene Rubber Market:

Ophthalmic Viscoelastic Devices Market:

Middle East And Africa Laundry Detergents Market:

North America Waterproofing Market:

Automotive Rear Occupant Alert System Market:

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, healthcare and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: Steven Luke, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA